MGO One Seven’s Lexicon Pharmaceuticals LXRX Stock Holding History

MGO One Seven’s Portfolio LXRX Stock Details LXRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	$0	Sell	24 -26	-52%	-$240	﹤0.01%	1844
2017 Q4	$0	Buy	+50	New	+$520	﹤0.01%	1792

Other funds holding LXRX

Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Ulys LLC New York $25.4M AUM 201.03% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

UIM

USS Investment Management London, United Kingdom $27.8B AUM 39.42% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

CLM

ClearBridge LLC (Maryland) Baltimore, Maryland $329M AUM 9.73% 1-Year Est. Return

MGO One Seven's LXRX Position: Q1 2018 in Review

MGO One Seven reduced its Lexicon Pharmaceuticals (LXRX) stake by 52% in Q1 2018, selling an estimated $240 and leaving 24 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #1844.

MGO One Seven first reported a position in LXRX in Q4 2017 and has held it in 2 quarters since. 126 funds tracked by Wall St. Rank hold LXRX as of Q1 2018.

MGO One Seven held 24 shares of Lexicon Pharmaceuticals worth $0 as of Q1 2018.
MGO One Seven sold 26 Lexicon Pharmaceuticals shares in Q1 2018, an estimated $240.
Lexicon Pharmaceuticals made up ﹤0.01% of MGO One Seven's portfolio in Q1 2018, its #1844 holding.
MGO One Seven first reported a position in Lexicon Pharmaceuticals in Q4 2017 and has held it in 2 quarters since.
126 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q1 2018.

Based on MGO One Seven's 13F filing for Q1 2018, filed 15 May 2018.